新诊断的高度骨肉瘤的预后因素-一项系统性审查
Elisa Tirtei1, Sascha Wilk Michelsen2, Lianne M Haveman3
1Department of Pediatric Oncology, Regina Margherita Children's Hospital, Turin, Italy.
Cancer medicine
|July 16, 2025
概括
这一系统性审查确定了骨髓瘤治疗前预后的关键因素,包括年龄,转移,瘤大小和部位. 需要进一步的研究来验证像循环瘤DNA这样的有希望的生物标志物.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 遗传学 遗传学 是一个
背景情况:
- 治疗前预后因素对于骨髓瘤管理和临床试验分层至关重要.
- 已确定的因素包括转移,瘤大小和部位;有争议的因素包括病理性骨折和组织学亚型.
- 目前没有确定的预后瘤生物标志物存在.
研究的目的:
- 系统地审查关于新诊断的骨髓瘤治疗前预后因素的证据.
- 为了确定患者分层的最佳切断值.
- 为了确定FOSTER-CabOS试验的潜在生物标志物.
主要方法:
- 在PubMed,Web-of-science和Embase (2000-2023) 的系统文献搜索.
- 包含和排除标准适用于49篇选定的论文.
- 在多个队列或验证研究中调查的14个因素的分析.
主要成果:
- 确认了患者年龄的预后值,转移的存在,瘤大小和部位 (轴与尾).
- 血清酸酸酶和乳酸脱酶显示出结果相关性,但独立性尚不清楚.
- 性别,病理性骨折,组织学亚型和P-糖蛋白表达的预后价值仍然不确定.
结论:
- 年龄,转移,瘤大小和部位是骨髓瘤的确诊预后因素.
- 循环瘤DNA和G1/G2RNA签名显示出作为新型生物标记物的前景.
- 建议对这些因素和生物标志物进行进一步的验证以获得临床应用.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456


